These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34297088)

  • 1. Letter to the Editor From Laidlaw et al: "Erythrocytosis in a Large Cohort of Transgender Men Using Testosterone: A Long-term Follow-up Study on Prevalence, Determinants, and Exposure Years".
    Laidlaw MK; Van Mol A; Van Meter Q; Hansen JE
    J Clin Endocrinol Metab; 2021 Nov; 106(12):e5275-e5276. PubMed ID: 34297088
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to Letter to the Editor From Laidlaw: "Erythrocytosis in a Large Cohort of Trans Men Using Testosterone: A Long-term Follow-up Study on Prevalence, Determinants, and Exposure Years".
    Madsen MC; van Dijk D; Wiepjes CM; Conemans EB; Thijs A; den Heijer M
    J Clin Endocrinol Metab; 2021 Oct; 106(11):e4791-e4792. PubMed ID: 34282457
    [No Abstract]   [Full Text] [Related]  

  • 3. Erythrocytosis in a Large Cohort of Trans Men Using Testosterone: A Long-Term Follow-Up Study on Prevalence, Determinants, and Exposure Years.
    Madsen MC; van Dijk D; Wiepjes CM; Conemans EB; Thijs A; den Heijer M
    J Clin Endocrinol Metab; 2021 May; 106(6):1710-1717. PubMed ID: 33599731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Letter to the Editor from Giovanelli and Quinton: "Erythrocytosis in a Large Cohort of Trans Men Using Testosterone: a Long-Term Follow-up Study on Prevalence, Determinants, and Exposure Years".
    Giovanelli L; Quinton R
    J Clin Endocrinol Metab; 2022 Jan; 107(1):e440-e441. PubMed ID: 34387315
    [No Abstract]   [Full Text] [Related]  

  • 5. Testosterone-induced erythrocytosis in transgender males: Challenges arising from an increasing prevalence of metabolic syndrome and wider therapeutic indications for prescribing SGLT2 inhibitor drugs.
    Mohammed A; Mamoojee YH; Quinton R
    Best Pract Res Clin Endocrinol Metab; 2024 Sep; 38(5):101930. PubMed ID: 39198051
    [No Abstract]   [Full Text] [Related]  

  • 6. Risk of erythrocytosis in transgender individuals undergoing testosterone therapy: a systematic review.
    Scala A; Graziani A; Vianello F; Ferlin A; Garolla A;
    Minerva Endocrinol (Torino); 2024 Jun; 49(2):205-216. PubMed ID: 39028210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythrocytosis Is Rare With Exogenous Testosterone in Gender-Affirming Hormone Therapy.
    Krishnamurthy N; Slack DJ; Kyweluk M; Cullen O; Kirkley J; Safer JD
    J Clin Endocrinol Metab; 2024 Apr; 109(5):1285-1290. PubMed ID: 38011684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trough serum testosterone predicts the development of polycythemia in hypogonadal men treated for up to 21 years with subcutaneous testosterone pellets.
    Ip FF; di Pierro I; Brown R; Cunningham I; Handelsman DJ; Liu PY
    Eur J Endocrinol; 2010 Feb; 162(2):385-90. PubMed ID: 19903801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence, Contributing Factors, and Implications for Clinical Management of Polycythemia in Transmasculine Patients on Testosterone.
    Tatarian J; Walcott Q; Richardson K
    LGBT Health; 2023 Jan; 10(1):72-79. PubMed ID: 35920834
    [No Abstract]   [Full Text] [Related]  

  • 10. Long term hormonal treatment for transgender people.
    den Heijer M; Bakker A; Gooren L
    BMJ; 2017 Nov; 359():j5027. PubMed ID: 29192092
    [No Abstract]   [Full Text] [Related]  

  • 11. Obstructive Sleep Apnea Is Associated With Polycythemia in Hypogonadal Men on Testosterone Replacement Therapy.
    Lundy SD; Parekh NV; Shoskes DA
    J Sex Med; 2020 Jul; 17(7):1297-1303. PubMed ID: 32307242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone treatment and MMPI-2 improvement in transgender men: a prospective controlled study.
    Keo-Meier CL; Herman LI; Reisner SL; Pardo ST; Sharp C; Babcock JC
    J Consult Clin Psychol; 2015 Feb; 83(1):143-56. PubMed ID: 25111431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian stimulation outcomes among transgender men compared with fertile cisgender women.
    Amir H; Yaish I; Samara N; Hasson J; Groutz A; Azem F
    J Assist Reprod Genet; 2020 Oct; 37(10):2463-2472. PubMed ID: 32719977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematocrit Response and Risk Factors for Significant Hematocrit Elevation with Implantable Testosterone Pellets.
    Hayden RP; Bennett NE; Tanrikut C
    J Urol; 2016 Dec; 196(6):1715-1720. PubMed ID: 27287525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated Dihydrotestosterone is Associated with Testosterone Induced Erythrocytosis.
    Aghazadeh M; Pastuszak AW; Johnson WG; McIntyre MG; Hsieh TM; Lipshultz LI
    J Urol; 2015 Jul; 194(1):160-5. PubMed ID: 25596360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of testosterone therapy on constructs related to aggression in transgender men: A systematic review.
    Kristensen TT; Christensen LL; Frystyk J; Glintborg D; T'Sjoen G; Roessler KK; Andersen MS
    Horm Behav; 2021 Feb; 128():104912. PubMed ID: 33309817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective Evaluation of Self-Reported Aggression in Transgender Persons.
    Defreyne J; T'Sjoen G; Bouman WP; Brewin N; Arcelus J
    J Sex Med; 2018 May; 15(5):768-776. PubMed ID: 29699761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of testosterone therapy on BMI, blood pressure, and laboratory profile of transgender men: a systematic review.
    Velho I; Fighera TM; Ziegelmann PK; Spritzer PM
    Andrology; 2017 Sep; 5(5):881-888. PubMed ID: 28709177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversible aquagenic pruritus associated with testosterone-induced erythrocytosis.
    Liu M; Shinkai K
    J Am Acad Dermatol; 2014 Jun; 70(6):e139-40. PubMed ID: 24831338
    [No Abstract]   [Full Text] [Related]  

  • 20. Association of subcutaneous testosterone pellet therapy with developing secondary polycythemia.
    Rotker KL; Alavian M; Nelson B; Baird GL; Miner MM; Sigman M; Hwang K
    Asian J Androl; 2018; 20(2):195-199. PubMed ID: 29205178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.